ITGA2B and autoimmune thrombocytopenic purpura: Anti-platelet antibodies are detected in approximately 60% of ITP patients, and they predominantly target platelet glycoprotein (GP) IIb/IIIa and/or the GP Ib–IX–V complex [29].